SANDS CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings71 positions
VISA INC | 16.5M | $2.2B | 7.8% | $124.91 | 0.00% | 1 qtr | First report 0 |
AMAZON COM INC | 1.4M | $2.1B | 7.4% | $75.10 | 0.00% | 1 qtr | First report 0 |
ALIBABA GROUP HLDG LTD | 15M | $2.1B | 7.3% | $128.99 | 0.00% | 1 qtr | First report 0 |
NETFLIX INC | 5.4M | $1.4B | 5.1% | $26.77 | 0.00% | 1 qtr | First report 0 |
ALPHABET INC | 1.2M | $1.3B | 4.5% | $51.76 | 0.00% | 1 qtr | First report 0 |
EDWARDS LIFESCIENCES CORP | 8M | $1.2B | 4.3% | $50.14 | 0.00% | 1 qtr | First report 0 |
SERVICENOW INC | 6.8M | $1.2B | 4.3% | $35.61 | 0.00% | 1 qtr | First report 0 |
SALESFORCE INC | 8.4M | $1.2B | 4.1% | $133.06 | 0.00% | 1 qtr | First report 0 |
ILLUMINA INC | 3.8M | $1.1B | 4.1% | $290.11 | 0.00% | 1 qtr | First report 0 |
WORKDAY INC | 6.2M | $997.7M | 3.6% | $159.56 | 0.00% | 1 qtr | First report 0 |
ADOBE INC | 3.9M | $875.9M | 3.1% | $223.13 | 0.00% | 1 qtr | First report 0 |
BOOKING HOLDINGS INC | 454,637 | $783.1M | 2.8% | $67.63 | 0.00% | 1 qtr | First report 0 |
REGENERON PHARMACEUTICALS | 2.1M | $777.2M | 2.8% | $360.62 | 0.00% | 1 qtr | First report 0 |
META PLATFORMS INC | 5.4M | $709.5M | 2.5% | $129.85 | 0.00% | 1 qtr | First report 0 |
ALIGN TECHNOLOGY INC | 3.3M | $688M | 2.5% | $208.29 | 0.00% | 1 qtr | First report 0 |
| 6.5M | $577.8M | 2.1% | — | — | 1 qtr | First report 0 | |
NIKE INC | 7.6M | $566.1M | 2.0% | $66.94 | 0.00% | 1 qtr | First report 0 |
Monster Beverage Corp | 11.1M | $547.3M | 2.0% | $24.61 | 0.00% | 1 qtr | First report 0 |
COSTAR GROUP INC | 1.6M | $536.1M | 1.9% | $33.73 | 0.00% | 1 qtr | First report 0 |
BIOMARIN PHARMACEUTICAL INC | 6.1M | $520.1M | 1.9% | $83.60 | 0.00% | 1 qtr | First report 0 |
SANDS CAPITAL MANAGEMENT, LLC manages $28B across 71 positions as of Q4 2018. Top holdings: V (7.8%), AMZN (7.4%), BABA (7.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.
First quarter we have for this fund: 71 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $28.0B across 71 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR